BIO International Convention
June 22-25, 2026
San Diego, USA
https://convention.bio.org/
News and Events
Subscribe to our press distribution list to receive the latest news about AMW.
Downloads
Upcoming
Events
CRS (Controlled Release Society) Annual Meeting
July 6-9, 2026
Lisbon, Portugal
https://www.controlledreleasesociety.org/events/crs-2026-annual-meeting-exposition
CPHI South East Asia
July 8-10, 2026
Bangkok, Thailand
https://www.cphi.com/sea/en/attend/attend/why-attend.html
CPHI Milan
October 6-8, 2026
Milan, Italy
https://www.cphi.com/europe/en/exhibit/book-your-stand-milan.html
PODD – Partnership Opportunities in Drug Delivery
October 29-30, 2026
Boston, USA
https://poddconference.com/
BIO-Europe
November 9-11, 2026
Cologne, Germany
https://informaconnect.com/bioeurope/
Past
Events
Archive
AT Uro Congress
May 22-24, 2025
Vienna, Austria
International Partnering in Life-Sciences Society (IPLS)
September 29 – October 1, 2025
Berlin, Germany
https://ipls.online/events/
CPHI Frankfurt
October 28-30, 2025
Frankfurt, Germany
https://www.cphi.com/europe/en/home.html
PharmaSynergyRx
February 5-6, 2026
London, UK
https://pharma-synergy-conference.com/pharmasynergy-2026/
EuroPLX
March 2-3, 2026
Lisbon, Portugal
https://www.raucon.com/euro-plx/euro-p-l-x-90
BIO-Europe Spring
March 23-25, 2026
Lisbon, Portugal
https://informaconnect.com/bioeurope-spring/
DCAT Week
March 23-26, 2026
New York City, USA
https://dcatweek.org/
PBP World Meeting
March 23-26, 2026
Prague, Czech Republic
https://worldmeeting.org/
analytica
March 24-27, 2026
Munich, Germany
https://analytica.de/de/muenchen/
ARVO Annual Meeting
May 3-7, 2026
Denver, USA
https://www.arvo.org/annual-meeting
Latest
News
AMW GmbH Executes on Growth Strategy with Record Sales and Increased Earnings for 2025
Warngau, Germany, April 13, 2026 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today reported financial results for the year ended December 31, 2025. AMW GmbH reported consolidated revenues for the 2025 financial year of EUR 44.6 million, an increase of 17% compared to the previous year (2024: EUR 38.2 million) and therefore […]
read moreAMW GmbH Further Strengthens Leadership Team by Appointing Dr. Joerg Serafimov to Managing Director and Promoting Senior Corporate Executives to C-Level Positions
Warngau, Germany, March 24, 2026 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced a substantial strengthening of its management team to further execute its growth strategy. Dr. Joerg Serafimov, the Company’s Chief Business Officer since January 2024, will join Philipp Karbach, CEO of AMW GmbH, as managing director. […]
read moreNew Shareholders joining AMW GmbH to Catalyze Long-term Growth Strategy Following Another Year of Record Sales
Warngau, Germany, March 5, 2026 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced a change in its shareholder structure. Ren Life Sciences, a specialist investment firm focused on advancing European life-sciences, and Juno Capital Partners, a global specialist company in the pharmaceuticals market based in Toronto, Canada, took […]
read moreAMW Strengthens Executive Leadership Team by Appointing Wolfram E. Scholl as Chief Operating Officer
Warngau, Germany, September 2, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the appointment of Wolfram E. Scholl as Chief Operating Officer (COO) as of September 1, 2025. As long-standing expert and consultant in supply chain management, he is responsible for production, quality, supply chain, engineering and […]
read moreAMW Secures Successful Long-term Growth Financing from Raiffeisenlandesbank Oberösterreich
Warngau, Germany, July 24, 2025 AMW GmbH, a specialty pharmaceutical company focused on biodegradable controlled-release drug delivery systems, today announced the closing of a significant financing agreement. This long-term and attractive financing from Raiffeisenlandesbank Oberösterreich allowed the Company to optimize its financing structure and to gain access to an additional line of credit. “With another […]
read more